Latest Insider Transactions at Aspira Women'S Health Inc. (AWH)
This section provides a real-time view of insider transactions for Aspira Women'S Health Inc. (AWH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aspira Women's Health Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aspira Women's Health Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Ellen O'Connor Vos |
BUY
Grant, award, or other acquisition
|
Direct |
29,109
+50.0%
|
-
|
|
Jun 01
2023
|
Winfred Parnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,232
+50.0%
|
-
|
|
Jun 01
2023
|
Stefanie L. Cavanaugh Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,623
+50.0%
|
-
|
|
Jun 01
2023
|
Jannie Prestridge Herchuk Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,039
+50.0%
|
-
|
|
Feb 09
2023
|
Robert D Auerbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,538
+19.41%
|
-
|
|
Feb 09
2023
|
Veronica Gh Jordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,225
+8.16%
|
-
|
|
Feb 09
2023
|
Ruby Sharma Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,115
+17.75%
|
-
|
|
Feb 09
2023
|
Celeste Rachelle Fralick Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,254
+28.14%
|
-
|
|
Aug 25
2022
|
Minh Hoang Merchant General Counsel and Secretary |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Aug 25
2022
|
Minh Hoang Merchant General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
26,667
+36.36%
|
-
|
|
Aug 25
2022
|
Ryan Thinh Phan CSO & COO |
BUY
Open market or private purchase
|
Direct |
46,667
+48.44%
|
-
|
|
Aug 25
2022
|
Celeste Rachelle Fralick Director |
BUY
Open market or private purchase
|
Direct |
6,667
+6.08%
|
-
|
|
Aug 25
2022
|
Ruby Sharma Director |
BUY
Open market or private purchase
|
Direct |
13,332
+9.46%
|
-
|
|
Aug 25
2022
|
Nicole Sandford Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
66,667
+35.32%
|
-
|
|
Aug 25
2022
|
Robert D Auerbach Director |
BUY
Open market or private purchase
|
Direct |
66,667
+35.43%
|
-
|
|
Aug 25
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
133,333
+0.52%
|
-
|
|
Jun 23
2022
|
Ruby Sharma Director |
BUY
Grant, award, or other acquisition
|
Direct |
114,218
+50.0%
|
-
|
|
Jun 23
2022
|
Robert D Auerbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
54,825
+50.0%
|
-
|
|
May 16
2022
|
Valerie Barber Palmieri Executive Chair |
BUY
Open market or private purchase
|
Direct |
43,994
+14.14%
|
$0
$0.57 P/Share
|
|
May 16
2022
|
Nicole Sandford Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
98,000
+41.85%
|
$0
$0.76 P/Share
|
|
Mar 31
2022
|
Nicole Sandford Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,033
+29.35%
|
-
|
|
Mar 31
2022
|
James T Lafrance Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,937
+12.82%
|
-
|
|
Mar 31
2022
|
Celeste Rachelle Fralick Director |
BUY
Grant, award, or other acquisition
|
Direct |
99,671
+50.0%
|
-
|
|
Mar 31
2022
|
Veronica Gh Jordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
73,656
+9.09%
|
-
|
|
Jun 24
2021
|
James T Lafrance Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+0.08%
|
-
|
|
May 06
2021
|
James T Lafrance Director |
BUY
Grant, award, or other acquisition
|
Direct |
423
+0.1%
|
-
|
|
Mar 19
2021
|
James T Lafrance Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,205
+2.13%
|
-
|
|
Mar 19
2021
|
David Schreiber Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,031
+2.3%
|
-
|
|
Mar 19
2021
|
Veronica Gh Jordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,442
+5.41%
|
-
|
|
Mar 19
2021
|
Nancy G Cocozza Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,680
+10.87%
|
-
|
|
Mar 19
2021
|
Sandra Elaine Brooks Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,728
+50.0%
|
-
|
|
Mar 19
2021
|
Nicole Sandford Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,902
+32.92%
|
-
|
|
Aug 31
2017
|
Larry N Feinberg > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
583,333
+5.6%
|
$583,333
$1.0 P/Share
|